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INTRODUCTION
Biliary magnetic resonance (MR) imaging using a 
hepatocyte-specific MR imaging contrast agent has been 
reported to be useful for detecting bronchobiliary fistula 
and active bile leakage after laparoscopic cholecystectomy 
(1-3). Nevertheless, to the best of our knowledge, there 
have been no reports describing biliary MR imaging 
using contrast agent in patients with biliary injury after 
radiofrequency ablation (RFA). This paper describes the 
first case of biliary peritonitis after RFA for hepatocellular 
carcinoma diagnosed by MR imaging with gadolinium 
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ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-
DTPA, a hepatocyte-specific MR imaging contrast agent).
CASE REPORT
An 80-year-old female with liver cirrhosis from hepatitis 
C was presented to our hospital with elevated serum alpha-
fetoprotein. Liver dynamic CT consisting of two phases 
was performed with a four-channel multi-detector row 
CT (LightSpeed QX/i; General Electric Medical Systems, 
Milwaukee, WI, USA). Two-phasic scanning was started 
with a 35-delay for the arterial phase, and a 90-second 
delay for the portal venous phase, after the beginning 
of contrast medium injection. The patient had a hepatic 
mass in segment VIII, which showed marked enhancement 
in the arterial phase and low attenuation compared to 
liver parenchyma in the portal venous phase, which was 
diagnosed as typical hepatocellular carcinoma (Fig. 1A, 
B). RFA was the most appropriate treatment as opposed 
to surgery, and was performed using three bipolar RF 
electrodes (CelonPOWER system; OLYMPUS Winter & Ibe 
GmbH, OLYMPUS, Japan) with a 30-mm exposed tip. 
http://dx.doi.org/10.3348/kjr.2013.14.6.914
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Fig. 1. Dynamic contrast-enhanced CT before RFA, contrast-enhanced CT after RFA, and Gd-EOB-DTPA-enhanced MRI two months 
after RFA in 80-year-old woman.
Dynamic contrast-enhanced CT images show 3-cm hepatic mass in segment VIII, which has marked enhancement in arterial phase (A) and low 
attenuation compared to liver parenchyma in portal venous phase (B) before RFA. Contrast-enhanced CT obtained seven days after RFA reveals 
ablated tumor with sufficient margin (C). Two months after RFA, enhanced T1-weighted images were acquired at 20 minutes (D), 60 minutes (E), 
and 300 minutes (F) after administration of Gd-EOB-DTPA. Enhanced T1-weighted MR imaging acquired at 300 minutes shows increased signal 
intensity in fluid collection around liver than that acquired at 20 and 60 minutes (arrowheads). Linear high signal areas to match RFA puncture 
route are also demonstrated in enhanced T1-weighted MR imaging at 300 minutes (arrows). RFA = radiofrequency ablation, Gd-EOB-DTPA = 
adolinium ethoxybenzyl diethylenetriaminepentaacetic acid
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Contrast-enhanced CT in the portal venous phase obtained 
seven days after RFA revealed an ablated tumor with 
sufficient margin (Fig. 1C). The patient had a good course 
and was discharged two weeks after RFA therapy.
Two months later, the patient had sudden upper 
abdominal pain, and underwent a dynamic contrast-
enhanced CT scan. The scan demonstrated marked 
enhancement on the surface of the liver, fluid collection 
around the liver, and dirty omentum. Biliary peritonitis was 
suspected. The next day, MR imaging with Gd-EOB-DTPA 
(Primovist, Bayer-Schering, Berlin, Germany) was performed 
to evaluate biliary leakage from the liver.
MRI examination was performed with a 1.5-T clinical unit 
(Signa EXCITE EchoSpeed Plus; General Electric Medical 
Systems, Milwaukee, WI, USA) using a TORSO coil. Liver 
Acquisition with Volume Acceleration sequence was used 
with the following parameters: TR/TE/FA: 5.3 ms/2.3 
ms/12°, 4.6-mm thickness without gap, and 320 x 192 
matrix. A bolus of 0.025 mmol/kg body weight Gd-EOB-DTPA 
was injected intravenously by a power injector at a rate of 1 
mL/s. Enhanced T1-weighted images were acquired 20, 60, 
and 300 minutes after the administration of Gd-EOB-DTPA 
(Fig. 1D-F). Enhanced T1-weighted MR imaging acquired at 
300 minutes showed increased signal intensity in the fluid 
collection around the liver than in the image acquired at 20 
minutes. Linear high signal areas to match the RFA puncture 
route were also demonstrated, suggesting a biliary leakage 
route from the bile duct to the fluid collection around 
the liver. Biliary peritonitis was diagnosed. Percutaneous 
drainage for fluid collection around the liver was performed, 
and the collected fluid was confirmed as bile. 
DISCUSSION
Gadolinium ethoxybenzyl diethylenetriaminepentaacetic 
acid is a bolus-injectable MRI contrast agent that allows 
for combined dynamic and hepatocyte-specific imaging 
in one examination. Approximately 50% of the Gd-EOB-
DTPA is excreted into the biliary system (1, 2). Excluding 
patients with severe liver dysfunction, it has been reported 
that T1-weighted images obtained 20 minutes after Gd-
EOB-DTPA injection show intense enhancement of the bile 
duct (1, 2). The extravasation of the contrast material is 
visualized as a hyperintense area in the T1-weighted image, 
and it has been reported in some cases that Gd-EOB-DTPA-
enhanced T1-weighted MR imaging can be used to evaluate 
the presence and exact location of bile leakage caused by 
cholecystectomy (3).
To our knowledge, there has been no report showing 
the usefulness of imaging for detecting bile leakage after 
RFA on MR imaging, CT, or hepatobililary scintigraphy. The 
incidence rate of biliary system complications of RFA, such 
as biloma, is a few percent, including mild cases, and many 
cases require no treatment (4-6). Biliary peritonitis is a 
rare complication caused by RFA, and it develops within 
one day after RFA (4). In the patient examined, the clinical 
course was atypical, and peritonitis could be diagnosed by 
CT, but it was difficult to definitively diagnose RFA-induced 
biliary peritonitis with CT. This case showed a characteristic 
finding in the T1-weighted image obtained 300 minutes 
after Gd-EOB-DTPA injection, in that extravasation of the 
contrast material was visualized as a marked hyperintense 
area. In addition, an extra-biliary enhanced area was 
observed along the route of RFA puncture, suggesting the 
pathway of bile leakage. 
To clearly detect the extravasation of contrast material, 
the optimal acquisition timing after Gd-EOB-DTPA 
administration should be investigated with consideration 
of the liver function and location of bile leakage. When 
the liver function is normal, the bile duct is favorably 
visualized within 30 minutes in Gd-EOB-DTPA-enhanced 
T1-weighted MR imaging (2). Reportedly, favorable images 
of the biliary tract can be acquired at about 2-3 hours 
after injection (7). However, the extravasation of contrast 
material may be poorly visualized even at 2 hours after 
injection in patients with severe hepatic cirrhosis (8). 
Moreover, the visualization level may vary depending 
on the location and severity of the bile duct injury. The 
leakage of bile after cholecystectomy was evaluated by 
enhanced T1-weighted MR imaging performed about 30 
minutes after MnDPDP administration in one report (3), 
and cholecystectomy-induced bile leakage was observed 
at 30 minutes after the administration of a contrast agent 
with hepatobililary scintigraphy or CT cholangiography 
after the administration of biliary intravenous contrast 
medium in other reports (9, 10). These studies suggest 
that the presence and exact location of bile leakage can 
be evaluated in images obtained within a relatively short 
time after the administration of a contrast agent, because 
a large volume of bile is leaked through the large bile duct. 
Also the extrahepatic bile duct lacks a protective system in 
extrahepatic bile duct injury against the leakage of bile like 
the liver parenchyma, so bile leakage is readily developed, 
and the extravasation of contrast material can be detected 
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in an image acquired in only a relatively early phase after 
contrast agent injection. In contrast, when the intrahepatic 
duct is injured, the volume of bile leakage is usually small, 
and the liver parenchyma plays a role in protecting against 
the leakage of bile, so the extravasation of contrast material 
may be overlooked in an image acquired in a relatively early 
phase after contrast medium injection. Although no report 
has discussed these points, images at several points in time 
after the administration of a contrast agent may be required 
to detect the slight extravasation of contrast material in 
patients with intrahepatic duct injury. 
In the patient examined, since intrahepatic bile duct 
injury was assumed, images were acquired at 3 points 
in time (20, 60, and 300 minutes after Gd-EOB-DTPA 
administration) to detect bile leakage. The image acquired 
at 300 minutes was the most useful for detecting bile 
leakage. In enhanced T1-weighted MR imaging performed 
about 300 minutes after the administration of Gd-EOB-
DTPA, visualization of the common bile duct was poor, while 
an increase in the signal intensity of fluid collected with 
leaked bile was observed, and the pathway of bile leakage 
was clearly demonstrated as a hyperintense area. In images 
acquired at 20 and 60 minutes, the common bile duct was 
well visualized, but the extravasation of contrast material 
was poorly observed because of the small volume of leaked 
bile, which made it difficult to definitively diagnose bile 
leakage. When intrahepatic bile duct injury is predicted, it 
may be necessary to evaluate images acquired at several 
hours after the administration of Gd-EOB-DTPA. 
In conclusion, the usefulness of T1-weighted MR image 
obtained 300 minutes after the intravenous injection of Gd-
EOB-DTPA for biliary peritonitis after RFA has been reported. 
It is important to decide on the acquisition timing with 
consideration of the predicted location of bile duct injury. 
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